After claiming its approval in Europe earlier this year, Abbott has secured the FDA’s go-ahead for its Volt pulsed field ablation system for irregular heart rhythms, a step forward in an | With the U.

Pheonix-Based Cardiology Group Continues to Expand Access to Care Across ValleyPHOENIX, Dec. 26, 2025 /PRNewswire/ -- ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

I felt fine, but my Whoop data told a different story. Paying attention led to early detection and a successful treatment.

The latest update is out from Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( ($AU:IMR) ). Imricor Medical Systems has ...

Blues Traveler frontman John Popper has had his share of health issues through the years, but what he faced in 2025 … well, the singer told Rolling Stone that it nearly killed him. And the way he got ...

Background The growing population of patients with adult congenital heart disease (ACHD) present complex lifelong care needs ...

Medications are the first-line treatment for atrial fibrillation, or A-fib. When they begin to fail, one option is ablation.

After approval in late 2024, Johnson & Johnson's Varipulse PFA system started 2025 on the wrong foot: Its early rollout had ...

Other hot topics included new data on LAAO and conduction-system pacing, plus the go-ahead for ablation in ASCs.

A session at the AHA Scientific Sessions 2025 focused on dilemmas related to antithrombotic therapy following catheter ablation in patients with AF.

Milestone Pharmaceuticals Inc.’s CARDAMYST nasal spray wins FDA approval for PSVT, but faces tough competition and market ...